✦ LIBER ✦

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954

✍ Scribed by Vass, S O; Jarrom, D; Wilson, W R; Hyde, E I; Searle, P F

Book ID: 110000061
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 359 KB
Volume: 100
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605094

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E. coli NfsA: an alternative nitroreduct

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954

✍ Vass, S O; Jarrom, D; Wilson, W R; Hyde, E I; Searle, P F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 359 KB

Prodrug activation gene therapy is a developing approach to cancer treatment, whereby prodrug-activating enzymes are expressed in tumour cells. After administration of a non-toxic prodrug, its conversion to cytotoxic metabolites directly kills tumour cells expressing the activating enzyme, whereas t

Enhanced efficacy of Escherichia coli ni

Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector

✍ Chen, M-J; Green, N K; Reynolds, G M; Flavell, J R; Mautner, V; Kerr, D J; Young 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 368 KB

E. coli Nitroreductase/CB1954: In Vitro

E. coli Nitroreductase/CB1954: In Vitro Studies into a Potential System for Feline Cancer Gene Therapy

✍ L. BLACKWOOD; P.J. O’SHAUGHNESSY; S.W.J. REID; D.J. ARGYLE 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB